Taiwan FDA registration 55dfa9e409e803127c21a496922d32ec
ABLTM 77 series acid-base blood gas and electrolyte analysis systems
TW: 〝瑞迪爾米達〞ABLTM 77 系列酸鹼血液氣體及電解質分析系統
Taiwan·Risk Class 2·SENDX MEDICAL, INC.·Registered Nov 17, 2005 – Nov 17, 2015CancelledRegistration details
- Analysis ID
- 55dfa9e409e803127c21a496922d32ec
- Customs Code
- DHA00601476901
Company information
- Manufacturer
- SENDX MEDICAL, INC.
- Manufacturer Country
- United States
- Authorized Representative
- BIOWAY CORPORATION
Product details
- Intended Use
- It can measure the acidity, carbon dioxide pressure, oxygen pressure, chlorine, calcium, silver, calium, and hemolysis ratio in the blood, and its measured data can provide experimental diagnostic analysis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Import Information
- import
Dates and status
- Registration Date
- Nov 17, 2005
- Expiry Date
- Nov 17, 2015
- Cancellation Date
- May 21, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for ABLTM 77 series acid-base blood gas and electrolyte analysis systems in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 55dfa9e409e803127c21a496922d32ec and manufactured by SENDX MEDICAL, INC.. The authorized representative in Taiwan is BIOWAY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices